Outpatient Anticoagulation

Outpatient Anticoagulation

Patients Receiving Chronic Anticoagulant or Antiplatelet Therapy

Patients receiving chronic anticoagulant or antiplatelet therapy for existing conditions should remain on their current regimen if positive for COVID-19, unless a new clot has developed, or ICU level of care requires a switch to parenteral/SubQ therapy

Assessment of All Other Patients

i.e. evidence of DVT/PE/positive Doppler or high clinical suspicion

Modified International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) VTE risk score ≥4; or Modified IMPROVE VTE risk score ≥2 and D-dimer level >2 times the upper limit of normal